Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
48-Hour Action Plan First, the governing principle One number matters more than all others: 4 million patients × 1/8,000 = ~500 patients at risk of liver failure over 5 years — some may already be experiencing it right now. Every decision below flows from this.Read the full answer